Netrin-1 has been reported to act as a novel promotor of cancer cell survival and invasiveness by inhibiting apoptosis through its receptors, such as DCC, Unc5 homologues (Unc5a, Unc5b, Unc5c and Unc5d) and Neo1 [13–15]. This evidence concerns the gene NTN1 and cancer.